Societe Generale Analysts Begin Coverage on Sanofi-Aventis (SNY)

By admin | 6 years ago

Equities researchers at Societe Generale assumed coverage on shares of Sanofi-Aventis (NYSE: SNY) in a report issued on Thursday. The firm set a “buy” rating on the stock.

Shares of Sanofi-Aventis traded up 1.34% during mid-day trading on Thursday, hitting $36.27. Sanofi-Aventis has a one year low of $30.98 and a one year high of $40.58. The company has a market cap of $96.025 billion and a P/E ratio of 11.69.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi-Aventis in a research note to investors on Tuesday, May 1st. They now have a $40.00 price target on the stock. Finally, analysts at JPMorgan Chase (NYSE: JPM) upgraded shares of Sanofi-Aventis from a “neutral” rating to an “overweight” rating in a research note to investors on Tuesday, March 6th.

Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products.

About the author